Skip to main content

Positive Bioscience launch genomic tests in India

 

Clinical courses

United States-based Myriad Genetics, the world's largest molecular diagnostic company, announced a strategic partnership with Positive Bioscience to offer the first of its kind molecular genomic testing in India. Genomic testing is still at an early stage in India and this partnership could revolutionise genomics testing in this country.

With this technologies, clinicians are able to diagnose cancer more precisely and advise their patients about the need for screening or treatment in order to save and improve patient’s lives.

These tests will help screen for cancer risks and enable families of cancer patients to take various preventive measures. All testing will be carried out at Myriad’s high quality labs in USA and Germany.

Genomic tests are available for 9 cancers: breast, pancreatic, ovarian, endometrial, melanoma, prostate, colon, lung & gastric.


<< Pharma News

Subscribe to PharmaTutor News Alerts by Email >>